Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Antagonists of activin-ActRIIa and uses for increasing red blood cell levels

Antagonists of activin-ActRIIa and uses for increasing red blood cell levels

US Patent 10093707 · Granted Oct 9, 2018

Estimated economic value: $31,461,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Methods of using ALK2 inhibitors2025
Methods of treating iron overload with a BMP inhibitor2025
Methods of using activin receptor type IIB variants2025
GDNF fusion polypeptides and methods of use thereof2025
Activin receptor type IIA variants and methods of use thereof2025
Activin receptor type IIa variants and methods of use thereof2025
ALK2 antibodies and methods of use thereof2025
Activin receptor type IIB variants and methods of use thereof2025
ALK1 receptor and ligand antagonists and uses thereof2024
GDNF fusion polypeptides and methods of use thereof2024
Activin receptor type IIB variants and methods of use thereof2024
Nucleic acid molecules encoding activin receptor type IIA variants2023